世界のHER2抗体市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global HER2 Antibody Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2801 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、HER2抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（トラスツズマブ、ラパチニブ、アド-トラスツズマブエムタンシン、ペルツズマブ、エベロリムス）、用途別市場規模（病院、医療センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・HER2抗体の市場動向 ・企業の競争状況、市場シェア ・HER2抗体の種類別市場規模（トラスツズマブ、ラパチニブ、アド-トラスツズマブエムタンシン、ペルツズマブ、エベロリムス） ・HER2抗体の用途別市場規模（病院、医療センター） ・HER2抗体の北米市場規模2016-2027（アメリカ、カナダ） ・HER2抗体のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・HER2抗体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・HER2抗体の中南米市場規模2016-2027（メキシコ、ブラジル） ・HER2抗体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Genentech Inc、Novartis AG、Pfizer、Abnova Corporation、InvivoGen、Celltrion、Biocon Limited、Bio-Techne） ・結論

HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-expressed. One year of trastuzumab therapy is recommended for all patients with HER2-positive breast cancer who are also receiving chemotherapy.

Market Analysis and Insights: Global HER2 Antibody Market
The global HER2 Antibody market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global HER2 Antibody market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global HER2 Antibody market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global HER2 Antibody market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global HER2 Antibody market.

Global HER2 Antibody Scope and Market Size
HER2 Antibody market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global HER2 Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Trastuzumab
Lapatinib
Ado-trastuzumab Emtansine
Pertuzumab
Everolimus

Segment by Application
Hospital
Medical Center

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Genentech Inc
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HER2 Antibody Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Trastuzumab
1.2.3 Lapatinib
1.2.4 Ado-trastuzumab Emtansine
1.2.5 Pertuzumab
1.2.6 Everolimus
1.3 Market by Application
1.3.1 Global HER2 Antibody Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Medical Center
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global HER2 Antibody Market Perspective (2016-2027)
2.2 HER2 Antibody Growth Trends by Regions
2.2.1 HER2 Antibody Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 HER2 Antibody Historic Market Share by Regions (2016-2021)
2.2.3 HER2 Antibody Forecasted Market Size by Regions (2022-2027)
2.3 HER2 Antibody Industry Dynamic
2.3.1 HER2 Antibody Market Trends
2.3.2 HER2 Antibody Market Drivers
2.3.3 HER2 Antibody Market Challenges
2.3.4 HER2 Antibody Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top HER2 Antibody Players by Revenue
3.1.1 Global Top HER2 Antibody Players by Revenue (2016-2021)
3.1.2 Global HER2 Antibody Revenue Market Share by Players (2016-2021)
3.2 Global HER2 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by HER2 Antibody Revenue
3.4 Global HER2 Antibody Market Concentration Ratio
3.4.1 Global HER2 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HER2 Antibody Revenue in 2020
3.5 HER2 Antibody Key Players Head office and Area Served
3.6 Key Players HER2 Antibody Product Solution and Service
3.7 Date of Enter into HER2 Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans

4 HER2 Antibody Breakdown Data by Type
4.1 Global HER2 Antibody Historic Market Size by Type (2016-2021)
4.2 Global HER2 Antibody Forecasted Market Size by Type (2022-2027)

5 HER2 Antibody Breakdown Data by Application
5.1 Global HER2 Antibody Historic Market Size by Application (2016-2021)
5.2 Global HER2 Antibody Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America HER2 Antibody Market Size (2016-2027)
6.2 North America HER2 Antibody Market Size by Type
6.2.1 North America HER2 Antibody Market Size by Type (2016-2021)
6.2.2 North America HER2 Antibody Market Size by Type (2022-2027)
6.2.3 North America HER2 Antibody Market Size by Type (2016-2027)
6.3 North America HER2 Antibody Market Size by Application
6.3.1 North America HER2 Antibody Market Size by Application (2016-2021)
6.3.2 North America HER2 Antibody Market Size by Application (2022-2027)
6.3.3 North America HER2 Antibody Market Size by Application (2016-2027)
6.4 North America HER2 Antibody Market Size by Country
6.4.1 North America HER2 Antibody Market Size by Country (2016-2021)
6.4.2 North America HER2 Antibody Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe HER2 Antibody Market Size (2016-2027)
7.2 Europe HER2 Antibody Market Size by Type
7.2.1 Europe HER2 Antibody Market Size by Type (2016-2021)
7.2.2 Europe HER2 Antibody Market Size by Type (2022-2027)
7.2.3 Europe HER2 Antibody Market Size by Type (2016-2027)
7.3 Europe HER2 Antibody Market Size by Application
7.3.1 Europe HER2 Antibody Market Size by Application (2016-2021)
7.3.2 Europe HER2 Antibody Market Size by Application (2022-2027)
7.3.3 Europe HER2 Antibody Market Size by Application (2016-2027)
7.4 Europe HER2 Antibody Market Size by Country
7.4.1 Europe HER2 Antibody Market Size by Country (2016-2021)
7.4.2 Europe HER2 Antibody Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific HER2 Antibody Market Size (2016-2027)
8.2 Asia-Pacific HER2 Antibody Market Size by Type
8.2.1 Asia-Pacific HER2 Antibody Market Size by Type (2016-2021)
8.2.2 Asia-Pacific HER2 Antibody Market Size by Type (2022-2027)
8.2.3 Asia-Pacific HER2 Antibody Market Size by Type (2016-2027)
8.3 Asia-Pacific HER2 Antibody Market Size by Application
8.3.1 Asia-Pacific HER2 Antibody Market Size by Application (2016-2021)
8.3.2 Asia-Pacific HER2 Antibody Market Size by Application (2022-2027)
8.3.3 Asia-Pacific HER2 Antibody Market Size by Application (2016-2027)
8.4 Asia-Pacific HER2 Antibody Market Size by Region
8.4.1 Asia-Pacific HER2 Antibody Market Size by Region (2016-2021)
8.4.2 Asia-Pacific HER2 Antibody Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America HER2 Antibody Market Size (2016-2027)
9.2 Latin America HER2 Antibody Market Size by Type
9.2.1 Latin America HER2 Antibody Market Size by Type (2016-2021)
9.2.2 Latin America HER2 Antibody Market Size by Type (2022-2027)
9.2.3 Latin America HER2 Antibody Market Size by Type (2016-2027)
9.3 Latin America HER2 Antibody Market Size by Application
9.3.1 Latin America HER2 Antibody Market Size by Application (2016-2021)
9.3.2 Latin America HER2 Antibody Market Size by Application (2022-2027)
9.3.3 Latin America HER2 Antibody Market Size by Application (2016-2027)
9.4 Latin America HER2 Antibody Market Size by Country
9.4.1 Latin America HER2 Antibody Market Size by Country (2016-2021)
9.4.2 Latin America HER2 Antibody Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa HER2 Antibody Market Size (2016-2027)
10.2 Middle East & Africa HER2 Antibody Market Size by Type
10.2.1 Middle East & Africa HER2 Antibody Market Size by Type (2016-2021)
10.2.2 Middle East & Africa HER2 Antibody Market Size by Type (2022-2027)
10.2.3 Middle East & Africa HER2 Antibody Market Size by Type (2016-2027)
10.3 Middle East & Africa HER2 Antibody Market Size by Application
10.3.1 Middle East & Africa HER2 Antibody Market Size by Application (2016-2021)
10.3.2 Middle East & Africa HER2 Antibody Market Size by Application (2022-2027)
10.3.3 Middle East & Africa HER2 Antibody Market Size by Application (2016-2027)
10.4 Middle East & Africa HER2 Antibody Market Size by Country
10.4.1 Middle East & Africa HER2 Antibody Market Size by Country (2016-2021)
10.4.2 Middle East & Africa HER2 Antibody Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Genentech Inc
11.1.1 Genentech Inc Company Details
11.1.2 Genentech Inc Business Overview
11.1.3 Genentech Inc HER2 Antibody Introduction
11.1.4 Genentech Inc Revenue in HER2 Antibody Business (2016-2021)
11.1.5 Genentech Inc Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG HER2 Antibody Introduction
11.2.4 Novartis AG Revenue in HER2 Antibody Business (2016-2021)
11.2.5 Novartis AG Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer HER2 Antibody Introduction
11.3.4 Pfizer Revenue in HER2 Antibody Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Abnova Corporation
11.4.1 Abnova Corporation Company Details
11.4.2 Abnova Corporation Business Overview
11.4.3 Abnova Corporation HER2 Antibody Introduction
11.4.4 Abnova Corporation Revenue in HER2 Antibody Business (2016-2021)
11.4.5 Abnova Corporation Recent Development
11.5 InvivoGen
11.5.1 InvivoGen Company Details
11.5.2 InvivoGen Business Overview
11.5.3 InvivoGen HER2 Antibody Introduction
11.5.4 InvivoGen Revenue in HER2 Antibody Business (2016-2021)
11.5.5 InvivoGen Recent Development
11.6 Celltrion
11.6.1 Celltrion Company Details
11.6.2 Celltrion Business Overview
11.6.3 Celltrion HER2 Antibody Introduction
11.6.4 Celltrion Revenue in HER2 Antibody Business (2016-2021)
11.6.5 Celltrion Recent Development
11.7 Biocon Limited
11.7.1 Biocon Limited Company Details
11.7.2 Biocon Limited Business Overview
11.7.3 Biocon Limited HER2 Antibody Introduction
11.7.4 Biocon Limited Revenue in HER2 Antibody Business (2016-2021)
11.7.5 Biocon Limited Recent Development
11.8 Bio-Techne
11.8.1 Bio-Techne Company Details
11.8.2 Bio-Techne Business Overview
11.8.3 Bio-Techne HER2 Antibody Introduction
11.8.4 Bio-Techne Revenue in HER2 Antibody Business (2016-2021)
11.8.5 Bio-Techne Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global HER2 Antibody Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Trastuzumab
Table 3. Key Players of Lapatinib
Table 4. Key Players of Ado-trastuzumab Emtansine
Table 5. Key Players of Pertuzumab
Table 6. Key Players of Everolimus
Table 7. Global HER2 Antibody Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global HER2 Antibody Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global HER2 Antibody Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global HER2 Antibody Market Share by Regions (2016-2021)
Table 11. Global HER2 Antibody Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global HER2 Antibody Market Share by Regions (2022-2027)
Table 13. HER2 Antibody Market Trends
Table 14. HER2 Antibody Market Drivers
Table 15. HER2 Antibody Market Challenges
Table 16. HER2 Antibody Market Restraints
Table 17. Global HER2 Antibody Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global HER2 Antibody Market Share by Players (2016-2021)
Table 19. Global Top HER2 Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER2 Antibody as of 2020)
Table 20. Ranking of Global Top HER2 Antibody Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by HER2 Antibody Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players HER2 Antibody Product Solution and Service
Table 24. Date of Enter into HER2 Antibody Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global HER2 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 27. Global HER2 Antibody Revenue Market Share by Type (2016-2021)
Table 28. Global HER2 Antibody Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global HER2 Antibody Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global HER2 Antibody Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global HER2 Antibody Revenue Market Share by Application (2016-2021)
Table 32. Global HER2 Antibody Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global HER2 Antibody Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America HER2 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 35. North America HER2 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America HER2 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 37. North America HER2 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America HER2 Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America HER2 Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe HER2 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe HER2 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe HER2 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe HER2 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe HER2 Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe HER2 Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific HER2 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific HER2 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific HER2 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific HER2 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific HER2 Antibody Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific HER2 Antibody Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America HER2 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America HER2 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America HER2 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America HER2 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America HER2 Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America HER2 Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa HER2 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa HER2 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa HER2 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa HER2 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa HER2 Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa HER2 Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 64. Genentech Inc Company Details
Table 65. Genentech Inc Business Overview
Table 66. Genentech Inc HER2 Antibody Product
Table 67. Genentech Inc Revenue in HER2 Antibody Business (2016-2021) & (US$ Million)
Table 68. Genentech Inc Recent Development
Table 69. Novartis AG Company Details
Table 70. Novartis AG Business Overview
Table 71. Novartis AG HER2 Antibody Product
Table 72. Novartis AG Revenue in HER2 Antibody Business (2016-2021) & (US$ Million)
Table 73. Novartis AG Recent Development
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer HER2 Antibody Product
Table 77. Pfizer Revenue in HER2 Antibody Business (2016-2021) & (US$ Million)
Table 78. Pfizer Recent Development
Table 79. Abnova Corporation Company Details
Table 80. Abnova Corporation Business Overview
Table 81. Abnova Corporation HER2 Antibody Product
Table 82. Abnova Corporation Revenue in HER2 Antibody Business (2016-2021) & (US$ Million)
Table 83. Abnova Corporation Recent Development
Table 84. InvivoGen Company Details
Table 85. InvivoGen Business Overview
Table 86. InvivoGen HER2 Antibody Product
Table 87. InvivoGen Revenue in HER2 Antibody Business (2016-2021) & (US$ Million)
Table 88. InvivoGen Recent Development
Table 89. Celltrion Company Details
Table 90. Celltrion Business Overview
Table 91. Celltrion HER2 Antibody Product
Table 92. Celltrion Revenue in HER2 Antibody Business (2016-2021) & (US$ Million)
Table 93. Celltrion Recent Development
Table 94. Biocon Limited Company Details
Table 95. Biocon Limited Business Overview
Table 96. Biocon Limited HER2 Antibody Product
Table 97. Biocon Limited Revenue in HER2 Antibody Business (2016-2021) & (US$ Million)
Table 98. Biocon Limited Recent Development
Table 99. Bio-Techne Company Details
Table 100. Bio-Techne Business Overview
Table 101. Bio-Techne Revenue in HER2 Antibody Business (2016-2021) & (US$ Million)
Table 102. Bio-Techne Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HER2 Antibody Market Share by Type: 2020 VS 2027
Figure 2. Trastuzumab Features
Figure 3. Lapatinib Features
Figure 4. Ado-trastuzumab Emtansine Features
Figure 5. Pertuzumab Features
Figure 6. Everolimus Features
Figure 7. Global HER2 Antibody Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Medical Center Case Studies
Figure 10. HER2 Antibody Report Years Considered
Figure 11. Global HER2 Antibody Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global HER2 Antibody Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global HER2 Antibody Market Share by Regions: 2020 VS 2027
Figure 14. Global HER2 Antibody Market Share by Regions (2022-2027)
Figure 15. Global HER2 Antibody Market Share by Players in 2020
Figure 16. Global Top HER2 Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER2 Antibody as of 2020
Figure 17. The Top 10 and 5 Players Market Share by HER2 Antibody Revenue in 2020
Figure 18. Global HER2 Antibody Revenue Market Share by Type (2016-2021)
Figure 19. Global HER2 Antibody Revenue Market Share by Type (2022-2027)
Figure 20. North America HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America HER2 Antibody Market Share by Type (2016-2027)
Figure 22. North America HER2 Antibody Market Share by Application (2016-2027)
Figure 23. North America HER2 Antibody Market Share by Country (2016-2027)
Figure 24. United States HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe HER2 Antibody Market Share by Type (2016-2027)
Figure 28. Europe HER2 Antibody Market Share by Application (2016-2027)
Figure 29. Europe HER2 Antibody Market Share by Country (2016-2027)
Figure 30. Germany HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific HER2 Antibody Market Share by Type (2016-2027)
Figure 38. Asia-Pacific HER2 Antibody Market Share by Application (2016-2027)
Figure 39. Asia-Pacific HER2 Antibody Market Share by Region (2016-2027)
Figure 40. China HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America HER2 Antibody Market Share by Type (2016-2027)
Figure 48. Latin America HER2 Antibody Market Share by Application (2016-2027)
Figure 49. Latin America HER2 Antibody Market Share by Country (2016-2027)
Figure 50. Mexico HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa HER2 Antibody Market Share by Type (2016-2027)
Figure 54. Middle East & Africa HER2 Antibody Market Share by Application (2016-2027)
Figure 55. Middle East & Africa HER2 Antibody Market Share by Country (2016-2027)
Figure 56. Turkey HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE HER2 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Genentech Inc Revenue Growth Rate in HER2 Antibody Business (2016-2021)
Figure 60. Novartis AG Revenue Growth Rate in HER2 Antibody Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in HER2 Antibody Business (2016-2021)
Figure 62. Abnova Corporation Revenue Growth Rate in HER2 Antibody Business (2016-2021)
Figure 63. InvivoGen Revenue Growth Rate in HER2 Antibody Business (2016-2021)
Figure 64. Celltrion Revenue Growth Rate in HER2 Antibody Business (2016-2021)
Figure 65. Biocon Limited Revenue Growth Rate in HER2 Antibody Business (2016-2021)
Figure 66. Bio-Techne Revenue Growth Rate in HER2 Antibody Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---